Peer Review History
| Original SubmissionMarch 9, 2021 |
|---|
|
PONE-D-21-07809 Is a higher altitude associated with shorter survival among at-risk neonates? PLOS ONE Dear Dr. Dueñas Espin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please follow the reviewers advice carefully. Please submit your revised manuscript by Jun 04 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kazumichi Fujioka Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 3. Please refer to the specific statistical analyses performed as well as any post-hoc corrections to correct for multiple comparisons. If these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting). 4. One of the noted authors is a group or consortium [“Score Bebé” project]. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General Comments: This paper showed that high altitude is a risk factor for neonatal mortality. There are some weaknesses in this paper, such as the lack of data on surviving neonates and the small number of facilities at elevations of 80-2750 meters. However, the results of this study are of higher quality than existing reports and provide significant evidence for an association between elevation and risk of neonatal death. Specific recommendations for minor revision: It seems to me that the intent of the research is difficult to convey. By shortening the introduction slightly and changing the order of the sentences, the intent of the study would be clearer. 1) line 64-84: How about changing it as follows? Scientific evidence has consistently shown that high altitude is associated with high neonatal mortality [9]. Specifically, in the prenatal phase, a pregnancy at high altitude has lower availability of iron, vitamins A and D, iodine [1], higher erythropoietic demands, reduced blood oxygen content [9], and a subsequent lower maternal oxygen delivery to the fetoplacental unit. These mechanisms could result in lower foetal growth [9] and in a decrease in placental weight, accompanied by a significant increase in the incidence of syncytial nodes, trophoblastic cells, and foetal capillaries with a large intervillous space and fewer villi. The disadvantages in oxygen diffusion can also contribute to low birth weight in full-term neonates, preeclampsia, and gestational hypertension [22]. Hence, the transition from oxygenation through the placenta to oxygenation through the lungs is poor in high altitudes [9] the transition period for neonates in high altitudes is longer; it means that, even in the absence of pulmonary disorders, neonates may experience arterial oxygen desaturation during the first week of life [9]. 2) line 85-89: I suggest that you remove this content from the introduction. It should be mentioned in the discussion. 3) line 90-94: I propose the following change. However, past studies have an ecological approach [10–13], small sample sizes [14], lack of consideration of individual confounders in the analyses (i.e., birth weight, gestational age, small for gestational age, Apgar scale, type of delivery, and the presence of specific comorbidities) [14], lack of contextual factors (i.e., differences in quality of care, type of health care facility [i.e., public or private], and level of care [15–17], and most of them only compared two or three altitude categories [10–14,18–20]. Despite the available conceptual model of stillbirth health determinants [21], this model does not include altitude as a determinant. This background represents an evidence-based conceptual framework that suggests that neonatal survival could be negatively associated with high altitude, especially among at-risk neonates. The current study aims to assess such association by setting survival among at risk neonates, as measured by days, as the primary outcome, using a nationwide information database. 4) line 304-306: This expression is difficult to understand as a limitation. I suggest you change it as follows. Second, the present study had a lack of data on individual socioeconomic factors –a strong neonatal health determinant– [3]. However, we believe that the aggregated data used in this analysis could capture such socioeconomic effects, resulting in robust estimations. 5) line 307-315: We recommend the following change. Also, when altitude is considered as a potential health determinant in the neonatal period, it is required to consider that the mother-baby binomial could carry genetic traits that are not well suited to their current environment. This might define their degree of adaptation to high altitude. Thus, affect their susceptibility to maladaptation problems that could increase mortality risk [2,23]. Neonatal mortality at high altitude in South America is reduced by maternal and paternal indigenous Andean ancestry, in a dose-dependent manner [33,34], mechanisms and genes related to the ancestry protective effect are related to enhanced uteroplacental blood flow [23,33,35,36]. Additionally, despite epigenetic mechanisms speculated to have a central role in human adaptation to high altitude, connecting environmental, physiological, and genomic factors, in short periods [33,35], it has been postulated that genetic adaptation requires longer periods to produce resistance to higher altitudes [14,33]. Therefore, we believe that missing ancestry information does not imply a significant source of bias in our findings. Reviewer #2: The manuscript presents a retrospective analysis of Ecuadorian neonates who died at≦28days of life, and assess the association between higher altitudes on survival time among at-risk neonates. The study concludes that higher altitudes are independently with shorter survival time. The following comments and suggestions will improve the manuscript: 1. Introduction: “fetal” is more common than “foetal” (L76, 78..), so you should change. 2. Result: you state that “Except for the percentage of small for gestational age, there were significant differences between the individual and contextual variables across altitude categories (Table 1).” Why are there significant differences in the background (the individual and contextual variables) at different altitudes? Please discuss about this. 3. Result: the altitude was categorized two patterns, (ⅰ)<10m, between 10 to <2500m, and ≧2500m, (ⅱ)<80m, between 80 to <2500m, from 2500 to <2750m, and ≧2750m. Please clarify why you have categorized in this way, and list any previous literature you have used as reference. 4.Result: you state that“(ⅱ)considering being attended at<80m as the reference, being attended between 80 to <2500m, from 2500 to <2750m, and ≧2750m there was 42%, 57% and 17% higher HR, respectively.”(page12, Line 220-222) Why do you think the HR of ≥2750m is the lowest? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Mitsuhiro Okamoto Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Is a higher altitude associated with shorter survival among at-risk neonates? PONE-D-21-07809R1 Dear Dr. Dueñas Espin, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Kazumichi Fujioka Academic Editor PLOS ONE Additional Editor Comments (optional): Sufficiently revised following reviewers advice. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-07809R1 Is a higher altitude associated with shorter survival among at-risk neonates? Dear Dr. Dueñas-Espin: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Kazumichi Fujioka Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .